AD scores were higher in CVID patients with low IgA than in CVID+IgA (Figure 4B; CVID–IgA and XLA vs. CVID+IgA p = 0.003 and p = 0.007, respectively). This evidence concerns the gene CD79A and Alzheimer disease.